BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
This Quarter Return
-2.31%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.53B
AUM Growth
+$1.53B
Cap. Flow
-$3.25M
Cap. Flow %
-0.21%
Top 10 Hldgs %
79.89%
Holding
32
New
1
Increased
4
Reduced
–
Closed
2

Top Buys

1
CRNX icon
Crinetics Pharmaceuticals
CRNX
$11.5M
2
NAUT icon
Nautilus Biotechnolgy
NAUT
$10.1M
3
DVAX icon
Dynavax Technologies
DVAX
$8.63M
4
PANA
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$5.01M
5
TNGX icon
Tango Therapeutics
TNGX
$4.8M

Top Sells

1
CNST
Constellation Pharmaceuticals, Inc.
CNST
$32.7M
2
PNT
POINT Biopharma Global Inc. Common Stock
PNT
$10.5M

Sector Composition

1 Healthcare 88.31%
2 Financials 2.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
$481M 31.49% 5,831,307 – –
AVIR icon
2
Atea Pharmaceuticals
AVIR
$267M
$121M 7.9% 5,615,659 – –
DVAX icon
3
Dynavax Technologies
DVAX
$1.19B
$116M 7.6% 11,771,708 +875,935 +8% +$8.63M
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$115M 7.53% 3,080,237 – –
ARQT icon
5
Arcutis Biotherapeutics
ARQT
$1.86B
$109M 7.12% 3,979,292 – –
ANNX icon
6
Annexon
ANNX
$226M
$73M 4.78% 3,241,628 – –
CCCC icon
7
C4 Therapeutics
CCCC
$185M
$62.1M 4.07% 1,642,209 – –
PHVS icon
8
Pharvaris
PHVS
$1.39B
$59.3M 3.88% 3,180,601 – –
MRSN icon
9
Mersana Therapeutics
MRSN
$36.5M
$50.2M 3.29% 3,695,667 – –
NRIX icon
10
Nurix Therapeutics
NRIX
$714M
$34.1M 2.23% 1,284,314 – –
CRNX icon
11
Crinetics Pharmaceuticals
CRNX
$2.92B
$31.7M 2.07% 1,679,701 +608,273 +57% +$11.5M
SYRS
12
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$31.5M 2.07% 5,785,036 – –
SLDB icon
13
Solid Biosciences
SLDB
$427M
$29M 1.9% 7,929,918 – –
MRNS
14
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$25.7M 1.68% 1,431,058 – –
APTX
15
DELISTED
Aptinyx Inc. Common Stock
APTX
$25.2M 1.65% 8,891,758 – –
KYMR icon
16
Kymera Therapeutics
KYMR
$2.95B
$23.3M 1.52% 479,605 – –
NAUT icon
17
Nautilus Biotechnolgy
NAUT
$85.9M
$20.2M 1.32% 2,000,000 +1,000,000 +100% +$10.1M
SVRA icon
18
Savara
SVRA
$567M
$19.8M 1.29% 11,622,598 – –
SYRE icon
19
Spyre Therapeutics
SYRE
$996M
$18.8M 1.23% 2,700,000 – –
BLUE
20
DELISTED
bluebird bio
BLUE
$17.2M 1.13% 538,179 – –
XFOR icon
21
X4 Pharmaceuticals
XFOR
$84.2M
$13.8M 0.9% 2,119,540 – –
TNGX icon
22
Tango Therapeutics
TNGX
$747M
$10.5M 0.69% 921,790 +421,790 +84% +$4.8M
RACB
23
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$10.1M 0.66% 1,000,000 – –
ARYD
24
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$7.5M 0.49% 700,000 – –
BLSA
25
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.13M 0.34% 487,500 – –
1
2